Concepedia

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee, Christian Niederau, Gerald Minuk, G. Idéo, Vincent G. Bain, Jenny Heathcote, Stefan Zeuzem, C. Trépo,

The Lancet · 1998 · 2.3K citations · 18 references

References

18

An Algorithm for the Grading of Activity in Chronic Hepatitis C

Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text

Medicine, Internal Medicine, Pathology +17

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology · 1981 · 3.6K citations · Full text

Medicine, Pathology, Hepatology +16

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Thierry Poynard, Pierre Bédossa, P Opolon · The Lancet · 1997 · 3K citations

Medicine, Internal Medicine, Pathology +16

Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C

Pierre Bédossa · Hepatology · 1994 · 2K citations · Full text

Medicine, Pathology, Diagnostic Pathology +16

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

Gary L. Davis, Rafael Esteban, Vinod K. Rustgi et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +9